EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNF122 promotes glioblastoma growth via the JAK2 / STAT3 /c‐Myc signaling Axis

Qingbao Xiao, Kaming Xue, Lin Li, Kai Zhu, Rong Fu, Zhiyong Xiong iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Qingbao Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Janus Kinase 2, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The E3 ubiquitin ligase is well recognized as a significant contributor to glioblastoma (GBM) progression and has promise as a prospective therapeutic target. This study explores the contribution of E3 ubiquitin ligase RNF122 in the GBM progression and the related molecular mechanisms.

Methods

RNF122 expression levels were evaluated using qRT‐PCR, WB, and IHC, while functional assays besides animal experiments were used to assess RNF122's effect on GBM progression. We also tested the RNF122 impact on JAK2/STAT3/c‐Myc signaling using WB.

Results

RNF122 was upregulated in GBM and correlated to the advanced stage and poor clinical outcomes, representing an independent prognostic factor. Based on functional assays, RNF122 promotes GBM growth and cell cycle, which was validated further in subsequent analyses by JAK2/STAT3/c‐Myc pathway activation. Moreover, JAK2/STAT3 signaling pathway inhibitor WP1066 can weaken the effect of overexpression RNF122 on promoting GBM progression.

Conclusion

Our results revealed that RNF122 caused an aggressive phenotype to GBM and was a poor prognosticator; thus, targeting RNF122 may be effectual in GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaJanus Kinase 2Proto-Oncogene Proteins c-mycSignal TransductionSTAT3 Transcription FactorUbiquitin-Protein LigasesAnimalsFemaleHumansMaleMiceMiddle AgedCell Line, TumorCell ProliferationIntracellular Signaling Peptides and ProteinsMice, Inbred BALB CMice, NudeMembrane Proteins

Stichwörter der Autor:innen

JAK/STAT/c‐MycRNF122glioblastomagrowth

Substanzen

Intracellular Signaling Peptides and ProteinsJAK2 protein, humanJanus Kinase 2MYC protein, humanNMI protein, humanProto-Oncogene Proteins c-mycring finger protein 122, humanSTAT3 protein, humanSTAT3 Transcription FactorUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Neurosurgery, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei, China.
  • Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Zhiyong Xiong

Zitieren

APA

Xiao, Q., Xue, K., Li, L., Zhu, K., Fu, R., & Xiong, Z. (2024). RNF122 promotes glioblastoma growth via the JAK2 / STAT3 /c‐Myc signaling Axis. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70017

Vancouver

Xiao Q, Xue K, Li L, Zhu K, Fu R, Xiong Z. RNF122 promotes glioblastoma growth via the JAK2 / STAT3 /c‐Myc signaling Axis. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70017

BibTeX
@article{Xiao2024,
  author = {Xiao, Qingbao and Xue, Kaming and Li, Lin and Zhu, Kai and Fu, Rong and Xiong, Zhiyong},
  title = {RNF122 promotes glioblastoma growth via the JAK2 / STAT3 /c‐Myc signaling Axis},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.70017}
}
Kostenlos starten →